Brain, Vol. 125, No. 2, 338-349,
February 1, 2002
© 2002 Oxford University Press
Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord
1 Netherlands Institute for Brain Research, Amsterdam, The Netherlands
Correspondence to: G. Wolswijk, Netherlands Institute for Brain Research, Meibergdreef 33, 1105 AZ, Amsterdam ZO, The Netherlands E-mail: G.Wolswijk{at}nih.knaw.nl
Lesions appearing in the CNS of patients in the chronic phase of the inflammatory, demyelinating disease multiple sclerosis often fail to repair, resulting in neurological dysfunction. This failure of remyelination appears, in many cases, to be due not to the destruction of the local oligodendrocyte precursor population, a source for new myelin-forming cells, but to the failure of the precursor cells to proliferate and differentiate, at least in brain lesions. The spinal cord is also a prominent site for lesions in multiple sclerosis, but nothing is known about the fate of the oligodendrocyte precursor population in this area. The present study has therefore analysed spinal cord samples with demyelination from 16 subjects with longstanding multiple sclerosis for the presence of oligodendrocyte precursor cells. Immunolabellings of 10 µm thick sections with the O4/anti-galactocerebroside (GalC) antibody combination, to visualize O4-positive, GalC-negative oligodendrocyte precursor cells, revealed that such cells were prevalent in many spinal cord lesions, with densities of up to 35 cells/mm2. Six of the spinal cord lesions contained 
3 O4-positive, GalC-negative cells/mm2, but such cells were widespread in brain lesions from these multiple sclerosis cases that were available for study (8–26 cells/mm2). The density of the O4-positive, GalC-negative oligodendrocyte precursor cells in all spinal cord and brain lesions studied thus far (n = 41) decreased significantly with declining numbers of debris-laden macrophages. In addition, lesions lacking macrophages tended to be derived from the older patients and there was a negative correlation between the density of the oligodendrocyte precursor cells and clinical age of the multiple sclerosis subject at death, and disease duration. The analysis further revealed that lesions from subjects with primary progressive and secondary progressive multiple sclerosis contained, on average, similar numbers of oligodendrocyte precursor cells/mm2 and that immature oligodendrocytes were only present in significant numbers in lesions with high precursor densities. Taken together, the present data suggest that there is a gradual reduction in the size of the O4-positive, GalC- negative oligodendrocyte precursor population with increasing age of the lesion, that the generation of new oligodendrocytes becomes increasingly more impaired and that lesions are not repopulated to a significant extent by migratory oligodendrocyte precursor cells present in the adjacent unaffected tissue. Hence, strategies intended to promote endogenous remyelination in multiple sclerosis patients should focus on both enhancing the long-term survival of oligodendrocyte precursor cells and on stimulating these cells to proliferate and differentiate into remyelinating oligodendrocytes.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. S. Baer, Y. A. Syed, S. U. Kang, D. Mitteregger, R. Vig, C. ffrench-Constant, R. J. M. Franklin, F. Altmann, G. Lubec, and M. R. Kotter Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling Brain, February 1, 2009; 132(2): 465 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Omari, S. E. Lutz, L. Santambrogio, S. A. Lira, and C. S. Raine Neuroprotection and Remyelination after Autoimmune Demyelination in Mice that Inducibly Overexpress CXCL1 Am. J. Pathol., January 1, 2009; 174(1): 164 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Buckley, P. Goldsmith, and R. J. M. Franklin Zebrafish myelination: a transparent model for remyelination? Dis. Model. Mech., November 1, 2008; 1(4-5): 221 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kuhlmann, V. Miron, Q. Cuo, C. Wegner, J. Antel, and W. Bruck Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis Brain, July 1, 2008; 131(7): 1749 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Nait-Oumesmar, N. Picard-Riera, C. Kerninon, L. Decker, D. Seilhean, G. U. Hoglinger, E. C. Hirsch, R. Reynolds, and A. Baron-Van Evercooren Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitors PNAS, March 13, 2007; 104(11): 4694 - 4699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sohn, J. Natale, L.-J. Chew, S. Belachew, Y. Cheng, A. Aguirre, J. Lytle, B. Nait-Oumesmar, C. Kerninon, M. Kanai-Azuma, et al. Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J. Neurosci., September 20, 2006; 26(38): 9722 - 9735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Imitola, T. Chitnis, and S. J. Khoury Insights Into the Molecular Pathogenesis of Progression in Multiple Sclerosis: Potential Implications for Future Therapies Arch Neurol, January 1, 2006; 63(1): 25 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Omari, G. R. John, S. C. Sealfon, and C. S. Raine CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis Brain, May 1, 2005; 128(5): 1003 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ruffini, T. E. Kennedy, and J. P. Antel Inflammation and Remyelination in the Central Nervous System: A Tale of Two Systems Am. J. Pathol., May 1, 2004; 164(5): 1519 - 1522. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hestiantoro and D. F. Swaab Changes in Estrogen Receptor-{alpha} and -{beta} in the Infundibular Nucleus of the Human Hypothalamus Are Related to the Occurrence of Alzheimer's Disease Neuropathology J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1912 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Lily, J. Palace, and A. Vincent Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study Brain, February 1, 2004; 127(2): 269 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Giraudon, P. Vincent, C. Vuaillat, O. Verlaeten, L. Cartier, A. Marie-Cardine, M. Mutin, A. Bensussan, M.-F. Belin, and L. Boumsell Semaphorin CD100 from Activated T Lymphocytes Induces Process Extension Collapse in Oligodendrocytes and Death of Immature Neural Cells J. Immunol., January 15, 2004; 172(2): 1246 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Imitola, E. Y. Snyder, and S. J. Khoury Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis Physiol Genomics, August 15, 2003; 14(3): 171 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. G. Geurts, G. Wolswijk, L. Bo, P. van der Valk, C. H. Polman, D. Troost, and E. Aronica Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis Brain, August 1, 2003; 126(8): 1755 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wolswijk and R. Balesar Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis Brain, July 1, 2003; 126(7): 1638 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Armstrong, T. Q. Le, E. E. Frost, R. C. Borke, and A. C. Vana Absence of Fibroblast Growth Factor 2 Promotes Oligodendroglial Repopulation of Demyelinated White Matter J. Neurosci., October 1, 2002; 22(19): 8574 - 8585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D M Chari and W F Blakemore New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation Multiple Sclerosis, August 1, 2002; 8(4): 271 - 277. [Abstract] [PDF]
|
|